David B. Weiner

32.7k citations

483 papers · 22.1k indexed · 5 hit papers · h-index 77

Impact in

Virology top 0.05%
- HIV Research and Treatment
Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Virology 160
- HIV Research and Treatment 157
Immunology 287
- Immunotherapy and Immune Responses 177
- Immune Cell Function and Interaction 117
- T-cell and B-cell Immunology 66

Co-authors: Jean Boyer Michele A. Kutzler William V. Williams Niranjan Y. Sardesai Kenneth E. Ugen Kar Muthumani Michael A. Chattergoon Jian Yan
Journals: Vaccine (52 papers)Molecular Therapy (22 papers)Human Vaccines & Immunotherapeutics (17 papers)DNA and Cell Biology (16 papers)The Journal of Immunology (15 papers)
Partner nations: United States Canada India

In The Last Decade

David B. Weiner

472 papers receiving 21.4k citations

Hit Papers

5 papers align trajectories log scale

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial 2024 · 111 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Medicine
2008 Nature Reviews Genetics
2005 Nature Biotechnology
1998 The Journal of Infectious Diseases
1993 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by David B. Weiner

Since Specialization

Citations

This map shows the geographic impact of David B. Weiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Weiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Weiner more than expected).

Fields of papers citing papers by David B. Weiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Weiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Weiner. The network helps show where David B. Weiner may publish in the future.

Co-authors

The 25 scholars most cited alongside David B. Weiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Weiner Line = papers co-authored together David B. Weiner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DNA-based immunotherapy for cancer: In vivo approaches for recalcitrant targets Molecular Therapy ·Pratik Bhojnagarwala, Frederick W. Schwartz, A. B. S. Jabbour-Khury, David B. Weiner	2025	1
2	Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies Molecular Therapy ·Shridevi A. Desai, Jacqueline D. Chu, Johann Iván, Bella Kissela, ليلى حليمي, LLOYD ROCKMORE, Rebekah Ann Brown, Abdoulaye Dera, E. Gary, A PLICHET, Elizabeth M. Parzych, David B. Weiner, Daniel W. Kulp, Ami Patel	2024	0
3	Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape Molecular Therapy — Oncolytics ·Daniel H. Park, Kevin Liaw, Pratik Bhojnagarwala, Xizhou Zhu, Jihae Choi, Ali Ali, Devivasha Bordoloi, E. Gary, Ryan P. O’Connell, Abhijeet J. Kulkarni, Thareen Withanage, Trevor R.F. Smith, Alfredo Perales‐Puchalt, Ami Patel, David B. Weiner	2023	11
4	Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein Biochemistry ·Axel Wiegandt, Kylie J. Martinez, Gabriela Canziani, Ljiljana Jelić, Laura Álvarez-Román, Fengwen Zhang, 泰寛平川, E. Gary, David B. Weiner, Paul D. Bieniasz, Sonia Navas, Barry R. O’Keefe, Naufal Arshad, Irwin Chaiken	2023	4
5	A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy JCI Insight ·Devivasha Bordoloi, Pratik Bhojnagarwala, Alfredo Perales‐Puchalt, Abhijeet J. Kulkarni, Xizhou Zhu, Kevin Liaw, Ryan P. O’Connell, Daniel H. Park, Daniel W. Kulp, Rugang Zhang, David B. Weiner	2022	14
6	SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients Journal of Clinical Microbiology ·Susanne N. Walker, Neethu Chokkalingam, Emma L. Reuschel, Mansi Purwar, Ziyang Xu, E. Gary, Kevin Y. Kim, Shridevi A. Desai, Katherine Schultheis, Jewell Walters, Stephanie Ramos, Kar Muthumani, Trevor R.F. Smith, Kate E. Broderick, Pablo Tebas, Ami Patel, David B. Weiner, Daniel W. Kulp	2020	42
7	A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control Cancer Immunology Research ·Ziyang Xu, Neethu Chokkalingam, Edgar Tello‐Ruiz, Megan C. Wise, Mamadou A. Bah, Susanne N. Walker, Nicholas J. Tursi, Paul D. Fisher, Katherine Schultheis, Kate E. Broderick, Laurent Humeau, Daniel W. Kulp, David B. Weiner	2020	21
8	A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge Cancer Immunology Research ·Elizabeth K. Duperret, Alfredo Perales‐Puchalt, Regina Stoltz, M.O. Garc ́a, Ana Isabel Chaidez, James L. Barlow, Amitabha Chaudhuri, Niranjan Y. Sardesai, David B. Weiner	2019	91
9	Engineered transfer RNAs for suppression of premature termination codons Nature Communications ·John D. Lueck, Jae Seok Yoon, Alfredo Perales‐Puchalt, سیدموسی حسینی, Daniel T. Infield, Mark A. Behlke, Aaditya Bhatia, David B. Weiner, William R. Skach, Paul B. McCray, Christopher A. Ahern	2019	105
10	Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo Cancer Research ·Elizabeth K. Duperret, Emily Garcia, Regina Stoltz, Ami Patel, Megan C. Wise, Alfredo Perales‐Puchalt, Trevor R.F. Smith, Kate E. Broderick, Emma L. Masteller, J. Joseph Kim, Laurent Humeau, Kar Muthumani, David B. Weiner	2018	49
11	A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy Clinical Cancer Research ·Elizabeth K. Duperret, Shujing Liu, Megan Paik, Emily Garcia, Regina Stoltz, Xiaoming Liu, Siti Aishah Abdul Wahab, Alfredo Perales‐Puchalt, Charles C. Reed, Jian Yan, Xiaowei Xu, David B. Weiner	2018	36
12	Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Clinical Cancer Research ·Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael Dallas, Dawson Knoblock, Jean Boyer, Jian Yan, Russell Vang, Amir Sada Khan, Laurent Humeau, Niranjan Y. Sardesai, J. Joseph Kim, Stanley A. Plotkin, David B. Weiner, Cornelia L. Trimble, Mark L. Bagarazzi	2017	34
13	Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice Clinical Cancer Research ·Elizabeth K. Duperret, Emily Garcia, Dylan T. Ammons, Alfredo Perales‐Puchalt, Megan C. Wise, Jian Yan, Charles C. Reed, David B. Weiner	2017	125
14	Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity Cancer Research ·Daniel O. Villarreal, Megan C. Wise, Jewell Walters, Emma L. Reuschel, Min Joung Choi, Nyamekye Obeng-Adjei, Jian Yan, Matthew P. Morrow, David B. Weiner	2014	111
15	Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses Science Translational Medicine ·Mark L. Bagarazzi, Jian Yan, Matthew P. Morrow, Xuefei Shen, Raphaëlle Parker, Jessica C. Lee, Mary Giffear, Panyupa Pankhong, Amir Sada Khan, Kate E. Broderick, Christine Knott, Feng Lin, Jean Boyer, Ruxandra Draghia‐Akli, E LIBSON, J. Joseph Kim, David B. Weiner, Niranjan Y. Sardesai	2012	229
16	Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity Blood ·Matthew P. Morrow, Panyupa Pankhong, Dominick J. Laddy, T. Ladshaw, Jian Yan, Валентина Владимировна Касперская, David B. Weiner	2009	128
17	Plasmid Immunization Primes Unique DTH Responses to HIV-1 _MN Envelope Epitopes as Compared to Recombinant Protein Vaccination PubMed ·Michael A. Chattergoon, L. MUELLER‐KUHRT, Tara M. Robinson, Zhiming Yuan, Jean Boyer, David B. Weiner	2002	1
18	Cancer vaccines: is the future now? Expert Review of Vaccines ·David B. Weiner, Joseph Kim	2002	4
19	Monoclonal Antibodies Define a Cellular Antigen Involved in HTLV-I Infection Hybridoma ·Michael G. Agadjanyan, Michael A. Chattergoon, Irina Petrushina, Mosi K. Bennett, Jong Kim, Kenneth E. Ugen, Thomas Kieber‐Emmons, David B. Weiner	1998	5
20	Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine Constructs Hepatology ·Katsutoshi Tokushige, Takaji Wakita, Catherine J. Pachuk, Darius Moradpour, David B. Weiner, V R Zurawski, Jack R. Wands	1996	77

About David B. Weiner

David B. Weiner is a scholar working on Virology, Immunology, Infectious Diseases, Biotechnology and Epidemiology, having authored 483 papers that have together received 22.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (177 papers), HIV Research and Treatment (157 papers), Immune Cell Function and Interaction (117 papers), T-cell and B-cell Immunology (66 papers), RNA Interference and Gene Delivery (50 papers), vaccines and immunoinformatics approaches (48 papers), Monoclonal and Polyclonal Antibodies Research (47 papers) and Virus-based gene therapy research (34 papers). The work is most often cited by research in Virology (5.2k citations), Immunology (10.8k citations), Infectious Diseases (4.8k citations), Biotechnology (1.6k citations) and Epidemiology (4.6k citations). David B. Weiner has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Jean Boyer, Michele A. Kutzler, William V. Williams, Niranjan Y. Sardesai, Kenneth E. Ugen, Kar Muthumani, Michael A. Chattergoon, Jian Yan, Devon J. Shedlock and Yosef Refaeli. Their work appears in journals such as Vaccine, Molecular Therapy, Human Vaccines & Immunotherapeutics, DNA and Cell Biology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact